SprosRadar
Find tenders
Tenders Electronic Daily (TED) · 803711-2026

Peptide Synthesis Machine

Key facts

StatusAwarded
Estimated valueValue not published
Submission deadlineDeadline not published
PublishedNov 18, 2026
BuyerUniversitetet i Oslo
CountryNorway · Oslo
CPV code38430000, 73111000
SourceTenders Electronic Daily (TED) ↗
Open official notice
Status
Awarded
Estimated value
Value not published
Submission deadline
Deadline not published
Published
Nov 18, 2026
Buyer
Universitetet i Oslo
Country
Norway
CPV code
38430000, 73111000
Source
Tenders Electronic Daily (TED)

Contract outcome & evergreen alternatives

This notice is no longer open for submissions. The original remains available for reference.

Awarded supplier / winnerRegistration / LEI numberCountryAwarded contract amountAward date
Gyros Protein Technologies AB
Uppsala, 75183
false
SE-REG: 556672-5429SwedenValue not publishedOct 26, 2026

Open tenders in this CPV category (CPV 38000000 · View CPV × country award matrix)

Tenders Electronic Daily (TED) · Poland

Poland – Optical aids – Sukcesywna dostawa komponentów niezbędnych do budowy urządzeń wchodzących w skład systemu długo zasięgowej, światłowodowej dystrybucji optycznej częstotliwości referencyjnej (budowa wraz z wdrożeniem) realizowanego w ramach projektu pn. „System mobilnych sensorów kwantowych z zegarami optycznymi zintegrowanych w sieciach telekomunikacyjnych Q-ChronoS” (dalej zwanych również „asortymentem”).

Buyer: Instytut Chemii Bioorganicznej Polskiej Akademii Nauk, Poznańskie Centrum Superkomputerowo-Sieciowe

Value not published

Closing soon

Submission deadline: Nov 26, 2026, 09:00 AM UTC

CPV: 38624000 · 38636100 · 38621000

Checked:

The original notice takes precedence. Its status and conditions can change after collection.

Description

The objective of the procurement The University of Oslo needs to procure an automated peptide synthesis platform to support research and education within peptide chemistry, antimicrobial peptides, bio materials, chemical biology, protein denomination, drug development and associated disciplines. The instrument shall function as a shared research infrastructure for several research groups and teaching activities, and contribute to educating candidates who are attractive for the biotechnology and pharmaceutical industry. Main functions and capacity The platform shall enable parallel synthesis of several peptide sequences in one run, without risk of cross reactions or protocol incompatibility, and with flexible synthesis scales from small volumes to a larger scale for biological testing and material applications. The system ́s bottle and reactor set up must facilitate "walk-away" synthesis of long peptides (over 40 amino acids) in scales up to approx. 1 mmol per reaction vessel/synthesis position, without a need for manual refilling of amino acids during the process. The platform shall be able to handle reaction volumes of up to approx. 400 mL per position. Technological requirements and compatibility The system must be compatible with a broad range of amino cy-shipping wirevates, connection reagents, resins and solvents, and not be limited to proprietary reagents. It shall support synthesis of demanding peptide sequences and advanced molecule architectures, including non-canonical amino acids, peptoids, folders, staplede peptides, click-chemistry and other chemically modified building blocks. The fluidic system and reaction vessels must be chemical resistant, including TFA, HFIP and bromoedic acid and the system shall be able to operate in an inert atmosphere to reduce unwanted side-reactions and oxidation. The software must provide flexible management of synthesis protocols, including additional steps, pre-activations, use of alternative ("green") solvents and additional reagents. Heating, green chemistry and solvents The university aims at reducing the use of DMF, which has traditionally been standard solvent in fixed phase peptide synthesis, and switch to more environmentally friendly alternatives. The solvents ́ polarity and viscosity are critical factors in this transition. Heating technology is therefore required, which functions independently of the solvent ́s polarity and other physical chemical qualities. The system must be based on induction heating or equivalent technology that is not dependent on solvent polarity, and thus enable broad use of green chemistry strategies. Traditional microwave heating that is heavily dependent on solvent polarisation is not considered sufficient for this purpose. Operational model, maintenance and safety. The platform shall be designed as a closed system under inert gas (positive nitrogen pressure) for reagent and solvent transport, with dedicated lines to avoid cross contamination. The system shall minimise reagent consumption, dead volumes and carry-over between synthesis courses. A system with a limited number of moving parts is required, and without needle transfers, robotic arms or mechanical pumps/valves that experience give higher maintenance needs. The system shall have functionality for automatic washing of resin at all affected positions if an error occurs during the synthesis, so that already synthesised peptides are maintained and the reagent loss is limited. There shall also be automatic cleaning protocols for the entire fluidic system, in order to prevent carry-over and ensure good condition over time. Cleavage, HSE and traceability The platform shall handle solvents, reagents and waste in a safe and environmentally responsible way, with the most automated handling of delivery and waste transport in order to minimise manual exposure. The system shall be able to complete the automatic cleavage process (based on TFA), so that users do not have to manually carry out this process in fume hoods. The software shall provide comprehensive logging, traceability and possibilities for method development across research groups, with user-configurable protocols, real-time monitoring of runs, automated data storage and full documentation of all relevant synthesis parameters over time. The instrument is expected to be used as a joint research infrastructure for a considerable number of projects and users and must therefore have high operational security, limited maintenance requirements and easily accessible technical support to ensure maximum uptime and long-term productivity.

Lots

  1. Peptide Synthesis Machine

    The objective of the procurement The University of Oslo needs to procure an automated peptide synthesis platform to support research and education within peptide chemistry, antimicrobial peptides, bio materials, chemical biology, protein denomination, drug development and associated disciplines. The instrument shall function as a shared research infrastructure for several research groups and teaching activities, and contribute to educating candidates who are attractive for the biotechnology and pharmaceutical industry. Main functions and capacity The platform shall enable parallel synthesis of several peptide sequences in one run, without risk of cross reactions or protocol incompatibility, and with flexible synthesis scales from small volumes to a larger scale for biological testing and material applications. The system ́s bottle and reactor set up must facilitate "walk-away" synthesis of long peptides (over 40 amino acids) in scales up to approx. 1 mmol per reaction vessel/synthesis position, without a need for manual refilling of amino acids during the process. The platform shall be able to handle reaction volumes of up to approx. 400 mL per position. Technological requirements and compatibility The system must be compatible with a broad range of amino cy-shipping wirevates, connection reagents, resins and solvents, and not be limited to proprietary reagents. It shall support synthesis of demanding peptide sequences and advanced molecule architectures, including non-canonical amino acids, peptoids, folders, staplede peptides, click-chemistry and other chemically modified building blocks. The fluidic system and reaction vessels must be chemical resistant, including TFA, HFIP and bromoedic acid and the system shall be able to operate in an inert atmosphere to reduce unwanted side-reactions and oxidation. The software must provide flexible management of synthesis protocols, including additional steps, pre-activations, use of alternative ("green") solvents and additi

Public business contacts

hege.fjellberg@admin.uio.no

+47 22 855050

Checked: